Speech-Language Pathologists in Pikesville, MD Accepting Medicare

92 Speech-Language Pathologists found. Showing 41 - 60

Melissa Dunne Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Sudbrook Ln Ste A, Pikesville, MD 21208 Phone: 443-918-5575

Taylor L Wach, B.S Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Sudbrook Ln Ste A, Pikesville, MD 21208 Phone: 410-358-1997

Elena Nicoll Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Sudbrook Ln Ste A, Pikesville, MD 21208 Phone: 410-358-1997

Kathryn Slack Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1700 Reisterstown Rd Ste 226, Pikesville, MD 21208 Phone: 410-846-4005

Achievements Therapy Services Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 409 Yeshiva Ln., 1a, Pikesville, MD 21208 Phone: 410-486-5292

Samantha Morgan Scherr Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Sudbrook Ln, Pikesville, MD 21208 Phone: 844-733-7823

Michaela Holcombe Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Sudbrook Ln Ste A, Pikesville, MD 21208 Phone: 410-358-1997

Megan Elizabeth Aylesworth, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3310 Woodvalley Dr, Pikesville, MD 21208 Phone: 443-809-1203

Lily Brow Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Sudbrook Ln Ste A, Pikesville, MD 21208 Phone: 410-358-1997    Fax: 866-840-6040

Mr. Richard Michael Passafiume Jr. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Sudbrook Ln Ste A, Pikesville, MD 21208 Phone: 410-358-1997

Mackenzie Pretty, M.ED., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1700 Reisterstown Rd Ste 219, Pikesville, MD 21208 Phone: 410-846-4005

Amulya Noone Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Sudbrook Ln Ste A, Pikesville, MD 21208 Phone: 410-358-1997

Samara Shalom, M.S. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1700 Reisterstown Rd Ste 226, Pikesville, MD 21208 Phone: 410-394-8794

Olivia Schnegelberger Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Sudbrook Ln Ste A, Pikesville, MD 21208 Phone: 410-358-1997

Kristen Demers-feddy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Sudbrook Ln Ste A, Pikesville, MD 21208 Phone: 410-358-1997    Fax: 866-840-6040

Mrs. Nechama Rochail Makovoz, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 409 Yeshiva Ln, Apt #3a, Pikesville, MD 21208 Phone: 410-484-4736

Shannnon Elaine Bobst Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Sudbrook Ln Ste A, Pikesville, MD 21208 Phone: 443-450-5871

Karen Axelson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7 Sudbrook Ln, Pikesville, MD 21208 Phone: 410-205-8440

Pamela Orsino Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Sudbrook Ln Ste A, Pikesville, MD 21208 Phone: 410-358-1997

Samantha Santy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Sudbrook Ln Ste A, Pikesville, MD 21208 Phone: 410-358-1997    Fax: 866-840-6040

News Archive

Research scientists develop bioengineered treatment for targeting pancreatic cancer

Research scientists from Massachusetts General Hospital, Boston, have developed a novel bioengineered treatment that has shown promise in targeting pancreatic cancer without causing damage to healthy noncancer cells, a typical problem of chemotherapy.

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

New data released demonstrates that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than chemotherapy alone in women with early-stage disease.

Pediatrician recommends red reflex vision test for all newborns

With the number of premature births and medically fragile infants now increasing in the U.S., a basic eye exam, including a red reflex test, should be given to all children shortly after birth, reports Angela Buffenn, M.D., M.P.H., Director of the Orbit and Eye Movement Institute at The Vision Center of Childrens Hospital Los Angeles.

Results reported for clinical trial for the treatment of depression using external trigeminal nerve stimulation

Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS™ on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy. Results from the 17-question Hamilton Depression Rating Scale (HDRS-17), a clinician-rated scale, showed a 50.0% reduction in depression and the Beck Depression Inventory (BDI), a self-reported scale, showed a 58.0% reduction in scores. Both scales achieved statistical significance. In the trial, subjects placed stimulating eTNS™ electrodes on their foreheads for 8 hours each night and their depression was measured every two weeks using recognized standard tests. eTNS was well tolerated and no serious adverse events occurred during the 8-week treatment period.

Read more Medical News

› Verified 4 days ago

• 1
• 2
• 3(current)
• 4
• 5